Mary Taglienti

946 citations
17 papers · 719 indexed · h-index 14
Topics
Renal and related cancers (14 papers)Genetic and Kidney Cyst Diseases (8 papers)Renal cell carcinoma treatment (7 papers)

In The Last Decade

Mary Taglienti

16 papers receiving 709 citations

Peers

Mary Taglienti
Comparison fields: 5 of 61
  • Molecular Biology 596
  • Genetics 232
  • Pulmonary and Respiratory Medicine 186
  • Nephrology 141
  • Pediatrics, Perinatology and Child Health 76
Replace Sunny Hartwig with:
Sunny Hartwig Canada
Antoine Reginensi Canada
Jingdong Shan Finland
Lori L. O’Brien United States
Diana M. Iglesias Canada
Shunji Itoh Japan
Joo-Seop Park United States
Kaya L. Andrews United States
Tamina Seeger‐Nukpezah Germany
E H Zackai United States
Mary Taglienti relative to Sunny Hartwig Canada Sunny Hartwig's profile →
Citations per field
00.5×1.6×
Sunny Hartwig · 1×
Citations per year

Countries citing papers authored by Mary Taglienti

Since Specialization
Citations

This map shows the geographic impact of Mary Taglienti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Taglienti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Taglienti more than expected).

Fields of papers citing papers by Mary Taglienti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Taglienti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Taglienti. The network helps show where Mary Taglienti may publish in the future.

Co-authorship network of co-authors of Mary Taglienti

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Taglienti. A scholar is included among the top collaborators of Mary Taglienti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Taglienti. Mary Taglienti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 0
2 2
3 25
4 14
5 7
6 88
7 41
8 20
9 52
10 57
11 28
12 58
13 100
14 68
15 82
16 30
17 47

About Mary Taglienti

Mary Taglienti is a scholar working on Genetics, Nephrology and Molecular Biology, having authored 17 papers that have together received 719 indexed citations. Recurring topics across this work include Renal and related cancers (14 papers), Genetic and Kidney Cyst Diseases (8 papers) and Renal cell carcinoma treatment (7 papers). The work is most often cited by research in Nephrology (141 citations), Molecular Biology (596 citations) and Genetics (232 citations). Mary Taglienti has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Jordan A. Kreidberg, Shan Qin, Jing Zhou, Sunny Hartwig, Jacqueline Ho, Martin Kann, Bree Rumballe, Melissa H. Little, Xiaobo Gao and Xing Chen. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026